We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
+13.03%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$975M
AUM Growth
-$45.1M
(-4.4%)
Cap. Flow
-$152M
Cap. Flow
% of AUM
-15.58%
Top 10 Holdings %
Top 10 Hldgs %
40.02%
Holding
119
New
28
Increased
26
Reduced
20
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$13.1M |
| 2 |
TLN
Talen Energy Corp
TLN
|
+$12.5M |
| 3 |
Enphase Energy
ENPH
|
+$10.6M |
| 4 |
Sprouts Farmers Market
SFM
|
+$8.68M |
| 5 |
Freshpet
FRPT
|
+$8.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$12.6M |
| 2 |
Merck
MRK
|
+$10.3M |
| 3 |
Arm
ARM
|
+$9.8M |
| 4 |
HubSpot
HUBS
|
+$9.73M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$9.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.64% |
| 2 | Technology | 25.53% |
| 3 | Consumer Discretionary | 14.66% |
| 4 | Industrials | 11.67% |
| 5 | Communication Services | 4.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Immunome
IMNM
$2.83B
| – | – |
-74,000
| Closed | -$895K |
|
102
monday.com
MNDY
$3.94B
| – | – |
-17,000
| Closed | -$4.09M |
|
|
103
Merck
MRK
$318B
| – | – |
-83,000
| Closed | -$10.3M |
|
104
PUT
Moderna
MRNA
$23.6B
| – | – |
-400
| Closed | -$4.75M |
|
105
Neurocrine Biosciences
NBIX
$16.6B
| – | – |
-44,500
| Closed | -$6.13M |
|
|
NVO
106
Novo Nordisk
NVO
$209B
| – | – |
-68,000
| Closed | -$9.71M |
|
107
PUT
On Holding
ONON
$12.5B
| – | – |
-500
| Closed | -$1.94M |
|
|
P
108
PUT
Everpure Inc
P
$29.9B
| – | – |
-500
| Closed | -$3.21M |
|
109
PUT
Invesco QQQ Trust
QQQ
$484B
| – | – |
-1,720
| Closed | -$82.4M |
|
110
RH
RH
$3.71B
| – | – |
-4,000
| Closed | -$978K |
|
111
Rivian
RIVN
$23.2B
| – | – |
-20,000
| Closed | -$268K |
|
112
Roivant Sciences
ROIV
$26.2B
| – | – |
-400,000
| Closed | -$4.23M |
|
113
PUT
Rapid7
RPD
$773M
| – | – |
-515
| Closed | -$2.23M |
|
114
CALL
SentinelOne
S
$7.34B
| – | – |
-2,000
| Closed | -$4.21M |
|
115
CALL
Starbucks
SBUX
$120B
| – | – |
-720
| Closed | -$5.61M |
|
116
CALL
Spotify
SPOT
$100B
| – | – |
-720
| Closed | -$22.6M |
|
117
PUT
Trex
TREX
$5.01B
| – | – |
-1,000
| Closed | -$7.41M |
|
118
Vertex Pharmaceuticals
VRTX
$126B
| – | – |
-13,000
| Closed | -$6.09M |
|
119
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| – | – |
-720
| Closed | -$6.68M |
|
Similar funds
AGA
ACM
LSA
GWA
HP
SC
IAM
VCM
Atika Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Atika Capital Management held 119 positions worth $975M, down 4.4% from $1.02B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Atika Capital Management withdrew a net $152M in Q3 2024, closing 35 positions and reducing 20 holdings. Its most notable exit was Apple, an estimated $12.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Atika Capital Management opened a new position in Talen Energy Corp worth $15.9M.
- Atika Capital Management's largest Q3 2024 buy was Talen Energy Corp: 89,000 shares worth $15.9M.
- Atika Capital Management added most to Amazon in Q3 2024, an estimated $13.1M increase.
- Atika Capital Management's biggest Q3 2024 reduction was Arm, cutting an estimated $9.8M.
- Atika Capital Management fully exited Apple in Q3 2024, selling an estimated $12.6M.
- Atika Capital Management's ten largest holdings make up 40% of its $975M portfolio in Q3 2024.
- Atika Capital Management opened 28 new positions and closed 35 in Q3 2024.
- Atika Capital Management's portfolio value fell 4.4% quarter-over-quarter to $975M.
Based on Atika Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.